EXHIBIT 31.2

I, Edward J. Weisberger, certify that:

1.    I  have reviewed this Annual Report on Form 10-KSB for  the
fiscal year ended December 31, 2007 of Igene Biotechnology, Inc.;

2.    Based  on  my knowledge, this report does not  contain  any
untrue  statement of a material fact or omit to state a  material
fact  necessary  to make the statements made,  in  light  of  the
circumstances  under  which  such  statements  were   made,   not
misleading with respect to the period covered by this report;

3.    Based on my knowledge, the financial statements, and  other
financial information included in this report, fairly present  in
all  material  respects  the  financial  condition,  results   of
operations and cash flows of the small business issuer as of, and
for, the periods presented in this report;

4.   The small business issuer's other certifying officers and  I
are  responsible  for  establishing  and  maintaining  disclosure
controls  and procedures (as defined in Exchange Act  Rules  13a-
15(e)   and   15d-15(e))  and  internal  control  over  financial
reporting  (as defined in Exchange Act Rules 13a-15(f)  and  15d-
15(f)) for the small business issuer and have:

     a)    Designed  such disclosure controls and procedures,  or
caused  such  disclosure controls and procedures to  be  designed
under  our  supervision,  to  ensure  that  material  information
relating to the small business issuer, including its consolidated
subsidiaries,  is  made  known  to  us  by  others  within  those
entities, particularly during the period in which this report  is
being prepared;

     b)     Designed   such  internal  control   over   financial
reporting,  or  caused  such  internal  control  over   financial
reporting  to  be  designed  under our  supervision,  to  provide
reasonable  assurance  regarding  the  reliability  of  financial
reporting  and  the  preparation  of  financial  statements   for
external   purposes   in  accordance  with   generally   accepted
accounting principles;

     c)    Evaluated  the  effectiveness of  the  small  business
issuer's disclosure controls and procedures and presented in this
report  our conclusions about the effectiveness of the disclosure
controls  and procedures, as of the end of the period covered  by
this report based on such evaluation; and

     d)    Disclosed  in  this report any  change  in  the  small
business  issuer's  internal  control  financial  reporting  that
occurred  during the small business issuer's most  recent  fiscal
quarter (the small business issuer's fourth fiscal quarter in the
case  of  an annual report) that has materially affected,  or  is
reasonably  likely  to  materially  affect,  the  small  business
issuer's internal control over financial reporting; and

5.    The small business issuer's other certifying officer and  I
have  disclosed, based on our most recent evaluation of  internal
control  over financial reporting, to the small business issuer's
auditors  and the audit committee of the small business  issuer's
board of directors (or persons performing the equivalent):

     a)   All significant deficiencies and material weaknesses in
the  design  or  operation  of internal  control  over  financial
reporting  which  are reasonably likely to adversely  affect  the
small business issuer's ability to record, process, summarize and
report financial information; and

     b)    Any  fraud,  whether  or not material,  that  involves
management or other employees who have a significant role in  the
small   business   issuer's  internal  control   over   financial
reporting.

Date: May 1, 2008

/S/ EDWARD J. WEISBERGER
___________________________
    EDWARD J. WEISBERGER
    Chief Financial Officer
    (principal financial officer)